We are live on ! Find out more
KAM

Krensavage Asset Management Portfolio holdings

AUM $256M
1-Year Est. Return 69.63%
This Fund
S&P 500
This Quarter Est. Return
-0.87%
1 Year Est. Return
+69.63%
3 Year Est. Return
+113.28%
5 Year Est. Return
+196.5%
10 Year Est. Return
+463.27%
AUM
$278M
AUM Growth
-$1.16M
Cap. Flow
+$3.55K
Cap. Flow %
0%
Top 10 Hldgs %
73.79%
Holding
23
New
1
Increased
18
Reduced
1
Closed
3

Top Buys

Rank Stock Value
1
SCMP
Sucampo Pharmaceuticals, Inc.
SCMP
+$12M
2
SHPG
Shire pic
SHPG
+$11.4M
3
UTHR icon
United Therapeutics
UTHR
+$5.78M
4
IPXL
Impax Laboratories, Inc.
IPXL
+$4.66M
5
IVC
Invacare Corporation
IVC
+$3.42M

Top Sells

Rank Stock Value
1
BXLT
BAXALTA INC COM STK (DE)
BXLT
+$29.7M
2
SPPI
Spectrum Pharmaceuticals Inc
SPPI
+$6.95M
3
ASRT
Assertio
ASRT
+$4.17M
4
HRC
HILL-ROM HOLDINGS, INC.
HRC
+$1.73M

Sector Composition

Rank Sector Weight
1 Healthcare 76.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UTHR icon
1
United Therapeutics
UTHR
$25.8B
$29.2M 10.5%
275,248
+51,803
+23% +$5.78M
OFIX icon
2
Orthofix Medical
OFIX
$477M
$27.4M 9.88%
646,446
+3,301
+0.5% +$144K
IPXL
3
DELISTED
Impax Laboratories, Inc.
IPXL
$21.1M 7.59%
730,817
+142,935
+24% +$4.66M
ENTA icon
4
Enanta Pharmaceuticals
ENTA
$366M
$20M 7.21%
906,930
+24,401
+3% +$639K
TEVA icon
5
Teva Pharmaceuticals
TEVA
$40.8B
$19.9M 7.18%
396,545
+2,026
+0.5% +$108K
AMGN icon
6
Amgen
AMGN
$208B
$19.1M 6.9%
125,802
+18,547
+17% +$2.88M
AVNS
7
DELISTED
Avanos Medical
AVNS
$18.7M 6.74%
575,206
+12,917
+2% +$396K
SCMP
8
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
$17.9M 6.45%
1,631,398
+1,073,169
+192% +$12M
CNMD icon
9
CONMED
CNMD
$1.39B
$15.7M 5.66%
329,142
+1,682
+0.5% +$71.2K
MRK icon
10
Merck
MRK
$322B
$14.8M 5.35%
269,900
+1,379
+0.5% +$73.4K
SRGA
11
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$13.1M 4.72%
121,600
+6,697
+6% +$784K
SHPG
12
DELISTED
Shire pic
SHPG
$11.6M 4.19%
+63,166
New +$11.4M
IVC
13
DELISTED
Invacare Corporation
IVC
$10.9M 3.94%
901,440
+289,955
+47% +$3.42M
AGN
14
DELISTED
Allergan plc
AGN
$6.1M 2.2%
26,416
+146
+0.6% +$33.7K
ASRT
15
DELISTED
Assertio
ASRT
$4.28M 1.54%
3,632
-3,818
-51% -$4.17M
VXRT
16
DELISTED
Vaxart
VXRT
$3.79M 1.37%
246,222
+1,258
+0.5% +$20.9K
DSCI
17
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
$3.59M 1.29%
910,703
+4,657
+0.5% +$17.4K
STRR
18
DELISTED
Star Equity Holdings
STRR
$2.48M 0.89%
9,624
+49
+0.5% +$13K
JNP
19
DELISTED
Juniper Pharmaceuticals, Inc. Common Stock
JNP
$2.02M 0.73%
287,755
+788
+0.3% +$5.55K
SPPI
20
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
– –
-1,092,162
Closed -$6.95M
HRC
21
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
– –
-34,442
Closed -$1.73M
BXLT
22
DELISTED
BAXALTA INC COM STK (DE)
BXLT
– –
-734,885
Closed -$29.7M

Similar funds

CIA
Corigliano Investment Advisers Raleigh, North Carolina $256M AUM 54.89% 1-Year Est. Return
2
2Xideas Kusnacht, Switzerland $255M AUM 0.46% 1-Year Est. Return
CIM
Caldwell Investment Management Toronto, Ontario, Canada $255M AUM 36.87% 1-Year Est. Return
JFG
Juno Financial Group Richmond, Virginia $255M AUM
PIP
Palisades Investment Partners Santa Monica, California $255M AUM 50.52% 1-Year Est. Return
LRIC
Long Road Investment Counsel Kalamazoo, Michigan $255M AUM 12.85% 1-Year Est. Return
GAMC
Garner Asset Management Corp Plano, Texas $255M AUM 22.93% 1-Year Est. Return
TIA
Tiemann Investment Advisors Menlo Park, California $255M AUM 21.35% 1-Year Est. Return

Krensavage Asset Management's Q2 2016 Portfolio in Review

As of Q2 2016, Krensavage Asset Management held 23 positions worth $278M, down 0.42% from $279M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

Krensavage Asset Management's Q2 2016 filing shows 1 new, 18 increased, 1 reduced and 3 closed positions. Its largest new stake was Shire pic: 63,166 shares worth $11.6M. The largest sale was BAXALTA INC COM STK (DE), an estimated $29.7M.

By sector, the portfolio is most concentrated in Healthcare at 76% of assets, up from 73% a quarter earlier.

  • Krensavage Asset Management's largest Q2 2016 buy was Shire pic: 63,166 shares worth $11.6M.
  • Krensavage Asset Management added most to Sucampo Pharmaceuticals, Inc. in Q2 2016, an estimated $12M increase.
  • Krensavage Asset Management's biggest Q2 2016 reduction was Assertio, cutting an estimated $4.17M.
  • Krensavage Asset Management fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $29.7M.
  • Krensavage Asset Management's ten largest holdings make up 74% of its $278M portfolio in Q2 2016.
  • Krensavage Asset Management opened 1 new position and closed 3 in Q2 2016.
  • Krensavage Asset Management's portfolio value fell 0.42% quarter-over-quarter to $278M.

Based on Krensavage Asset Management's 13F filing for Q2 2016, filed 12 Aug 2016.